Heart failure and sleep disorders.

Obesity, Cardiovascular Disease and Sleep Disorders: Insights into the Rising Epidemic. J Sleep Disord Ther (2017) 0.75

The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med (1993) 35.93

Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep (1999) 23.64

Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med (2000) 18.12

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J (2012) 16.00

Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med (2001) 12.29

Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure. N Engl J Med (2015) 8.61

Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med (2009) 8.18

Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol (2013) 7.31

Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol (2000) 7.17

Obstructive sleep apnoea. Lancet (2002) 6.37

Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med (2005) 6.20

Sleep apnea and cardiovascular disease: an American Heart Association/american College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation (2008) 5.87

Air Versus Oxygen in ST-Segment-Elevation Myocardial Infarction. Circulation (2015) 5.05

Benefit of atrial pacing in sleep apnea syndrome. N Engl J Med (2002) 4.89

Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation (2002) 4.77

Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation (1998) 4.56

Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med (2003) 4.16

Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med (1999) 4.09

Obstructive sleep apnoea and its cardiovascular consequences. Lancet (2008) 3.73

Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation (2007) 3.27

Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med (2002) 3.16

The scoring of respiratory events in sleep: reliability and validity. J Clin Sleep Med (2007) 3.07

State of the science: promoting self-care in persons with heart failure: a scientific statement from the American Heart Association. Circulation (2009) 3.05

Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation (2003) 2.98

Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med (2003) 2.96

Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation (2000) 2.83

Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol (2007) 2.81

Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med (2001) 2.72

Sleep and exertional periodic breathing in chronic heart failure: prognostic importance and interdependence. Circulation (2005) 2.70

Central sleep apnea: Pathophysiology and treatment. Chest (2007) 2.59

Sleep apnoea in heart failure. Eur Respir J (2007) 2.56

Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med (2000) 2.55

Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation (1999) 2.55

Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea. Arch Intern Med (2006) 2.53

Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation (2001) 2.50

Sleep deprivation as a neurobiologic and physiologic stressor: Allostasis and allostatic load. Metabolism (2006) 2.48

Does this patient have obstructive sleep apnea?: The Rational Clinical Examination systematic review. JAMA (2013) 2.40

Rehospitalization for heart failure: predict or prevent? Circulation (2012) 2.36

Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail (2006) 2.33

Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation (2000) 2.29

Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. J Am Coll Cardiol (2007) 2.29

Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med (1996) 2.29

Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure. Eur Heart J (2010) 2.19

Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med (1996) 2.15

Sleepiness, fatigue, tiredness, and lack of energy in obstructive sleep apnea. Chest (2000) 2.15

Cheyne-Stokes respiration: friend or foe? Thorax (2012) 2.11

Sleep apnea and heart failure: Part II: central sleep apnea. Circulation (2003) 2.10

Sleep apnea and heart failure: Part I: obstructive sleep apnea. Circulation (2003) 2.06

Plasma norepinephrine in congestive heart failure. Am J Cardiol (1978) 2.05

Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation. A critical appraisal. Hypertension (1995) 2.04

Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. J Appl Physiol (1985) (1989) 2.04

Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis. Health Technol Assess (2009) 2.03

How to measure baroreflex sensitivity: from the cardiovascular laboratory to daily life. J Hypertens (2000) 2.02

Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med (2000) 1.97

Effects of dynamic bilevel positive airway pressure support on central sleep apnea in men with heart failure. Chest (2007) 1.91

Sleep-disordered breathing in heart failure with normal left ventricular ejection fraction. Eur J Heart Fail (2009) 1.91

The treatment of central sleep apnea syndromes in adults: practice parameters with an evidence-based literature review and meta-analyses. Sleep (2012) 1.83

Hemodynamic effects of simulated obstructive apneas in humans with and without heart failure. Chest (2001) 1.82

The efficacy of multilevel surgery of the upper airway in adults with obstructive sleep apnea/hypopnea syndrome. Laryngoscope (2008) 1.81

The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care. Can J Cardiol (2011) 1.78

Position paper on the management of patients with obstructive sleep apnea and hypertension: joint recommendations by the European Society of Hypertension, by the European Respiratory Society and by the members of European COST (COoperation in Scientific and Technological research) ACTION B26 on obstructive sleep apnea. J Hypertens (2012) 1.77

Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure. Circulation (2000) 1.75

Daytime Cheyne-Stokes respiration in ambulatory patients with severe congestive heart failure is associated with increased mortality. Chest (2007) 1.73

Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med (1995) 1.70

Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation (1999) 1.69

Recommendations for the management of patients with obstructive sleep apnoea and hypertension. Eur Respir J (2013) 1.66

High prevalence and persistence of sleep apnoea in patients referred for acute left ventricular failure and medically treated over 2 months. Eur Heart J (1999) 1.63

Effect of oxygen on sleep quality, cognitive function and sympathetic activity in patients with chronic heart failure and Cheyne-Stokes respiration. Eur Heart J (1998) 1.61

Sleep apnea and cardiovascular disease: a bidirectional relationship. Circulation (2012) 1.57

Increased long-term mortality in heart failure due to sleep apnoea is not yet proven. Eur Respir J (2004) 1.56

Continuous positive airway pressure improves daytime baroreflex sensitivity and nitric oxide production in patients with moderate to severe obstructive sleep apnea syndrome. Hypertens Res (2007) 1.56

Mechanisms of apnea. Prog Cardiovasc Dis (2008) 1.53

Relationship of systolic BP to obstructive sleep apnea in patients with heart failure. Chest (2003) 1.48

Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation (1998) 1.48

Exposure to hypoxia produces long-lasting sympathetic activation in humans. J Appl Physiol (1985) (2001) 1.48

Leftward septal displacement during right ventricular loading in man. Circulation (1980) 1.46

Central sleep apnea and Cheyne-Stokes respiration. Proc Am Thorac Soc (2008) 1.45

Interaction of sleep state and chemical stimuli in sustaining rhythmic ventilation. J Appl Physiol Respir Environ Exerc Physiol (1983) 1.42

Prevalence and Predictors of Sleep-Disordered Breathing in Patients With Stable Chronic Heart Failure: The SchlaHF Registry. JACC Heart Fail (2015) 1.39

Vascular inflammation in obesity and sleep apnea. Circulation (2010) 1.38

Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. J Clin Sleep Med (2013) 1.35

The effect of oxygen on respiration and sleep in patients with congestive heart failure. Ann Intern Med (1989) 1.33

Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk. Am J Physiol Regul Integr Comp Physiol (2007) 1.32

Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure. Lancet (1991) 1.32

Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. Am J Respir Crit Care Med (1995) 1.30

Fluid shift by lower body positive pressure increases pharyngeal resistance in healthy subjects. Am J Respir Crit Care Med (2006) 1.29

Slow breathing increases arterial baroreflex sensitivity in patients with chronic heart failure. Circulation (2002) 1.27

Susceptibility to periodic breathing with assisted ventilation during sleep in normal subjects. J Appl Physiol (1985) (1998) 1.27

Role of nocturnal rostral fluid shift in the pathogenesis of obstructive and central sleep apnoea. J Physiol (2012) 1.27

Continuous recording of the pulmonary and systemic arterial pressure during sleep in syndromes of hypersomnia with periodic breathing. Bull Physiopathol Respir (Nancy) (1973) 1.27

Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea. J Hypertens (1996) 1.26

Comorbid insomnia and obstructive sleep apnea: challenges for clinical practice and research. J Clin Sleep Med (2010) 1.25

Overnight shift from obstructive to central apneas in patients with heart failure: role of PCO2 and circulatory delay. Circulation (2001) 1.24

Sleep-induced periodic breathing and apnea: a theoretical study. J Appl Physiol (1985) (1991) 1.24

Sleep apnoea and nocturnal angina. Lancet (1995) 1.19

Immediate effects of arousal from sleep on cardiac autonomic outflow in the absence of breathing in dogs. J Appl Physiol (1985) (1995) 1.18

Combined increased chemosensitivity to hypoxia and hypercapnia as a prognosticator in heart failure. J Am Coll Cardiol (2009) 1.18

Prognosis of patients with heart failure and obstructive sleep apnea treated with continuous positive airway pressure. Chest (2008) 1.18

Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. J Am Coll Cardiol (1993) 1.17

Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation (2007) 1.17